<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H842C9E7D7F2047FB94AC9489FC94D0C0" public-private="public">
	<form>
		<distribution-code display="yes">I</distribution-code>
		<congress>112th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>H. R. 3622</legis-num>
		<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action>
			<action-date date="20111208">December 8, 2011</action-date>
			<action-desc><sponsor name-id="I000057">Mr. Israel</sponsor> (for
			 himself, <cosponsor name-id="T000462">Mr. Tiberi</cosponsor>,
			 <cosponsor name-id="G000551">Mr. Grijalva</cosponsor>,
			 <cosponsor name-id="H000627">Mr. Hinchey</cosponsor>,
			 <cosponsor name-id="E000288">Mr. Ellison</cosponsor>,
			 <cosponsor name-id="F000339">Mr. Frank of Massachusetts</cosponsor>, and
			 <cosponsor name-id="N000147">Ms. Norton</cosponsor>) introduced the following
			 bill; which was referred to the <committee-name committee-id="HIF00">Committee
			 on Energy and Commerce</committee-name>, and in addition to the Committee on
			 <committee-name committee-id="HWM00">Ways and Means</committee-name>, for a
			 period to be subsequently determined by the Speaker, in each case for
			 consideration of such provisions as fall within the jurisdiction of the
			 committee concerned</action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To amend title XVIII of the Social Security Act to
		  provide comprehensive cancer patient treatment education under the Medicare
		  program and to provide for research to improve cancer symptom
		  management.</official-title>
	</form>
	<legis-body id="H54010F57BDCB49EC8889CF62E8D73978" style="OLC">
		<section id="HB2B2309D9ABA4F96AD692D3E5289EC31" section-type="section-one"><enum>1.</enum><header>Short title; table of
			 contents</header>
			<subsection id="H121EDAB8D0CF4F3A8E0D93310CAA09DC"><enum>(a)</enum><header>Short
			 title</header><text display-inline="yes-display-inline">This Act may be cited
			 as the <quote><short-title>Assuring and Improving Cancer
			 Treatment Education and Cancer Symptom Management Act of
			 2011</short-title></quote>.</text>
			</subsection><subsection id="HB76F7842ADC5447CABD5B48D8D52A1D3"><enum>(b)</enum><header>Table of
			 contents</header><text>The table of contents of this Act is as follows:</text>
				<toc container-level="legis-body-container" lowest-bolded-level="division-lowest-bolded" lowest-level="section" quoted-block="no-quoted-block" regeneration="yes-regeneration">
					<toc-entry idref="HB2B2309D9ABA4F96AD692D3E5289EC31" level="section">Sec. 1. Short title; table of contents.</toc-entry>
					<toc-entry idref="H53D72594CA854B7EBC2DCA08D67AC091" level="section">Sec. 2. Findings.</toc-entry>
					<toc-entry idref="H1F8E940CB849465990D684BA8759D63C" level="title">Title I—Comprehensive Cancer Patient Treatment Education Under
				the Medicare Program</toc-entry>
					<toc-entry idref="H1F5D8016FDB2454D873B25A0B91FEB03" level="section">Sec. 101. Medicare coverage of comprehensive cancer patient
				treatment education services.</toc-entry>
					<toc-entry idref="H4B1818EE03BD4778A12A404C3B1C62BC" level="title">Title II—Research on Cancer Symptom Management
				Improvement</toc-entry>
					<toc-entry idref="HDD88B0627C8746F48208DBDCAE9E717B" level="section">Sec. 201. Expansion of research.</toc-entry>
					<toc-entry idref="H8D1A995536F54E58BA82A0AE095AA283" level="section">Sec. 202. Nursing intervention research grants.</toc-entry>
					<toc-entry idref="H5E7CF76D03224FDE8F010EB08E09CEBB" level="section">Sec. 203. Institute of Medicine study on the provision of
				symptom management and supportive care in people with cancer.</toc-entry>
				</toc>
			</subsection></section><section id="H53D72594CA854B7EBC2DCA08D67AC091"><enum>2.</enum><header>Findings</header><text display-inline="no-display-inline">The Congress makes the following
			 findings:</text>
			<paragraph id="HC17120BDA118418E9C41BCC06B518FD1"><enum>(1)</enum><text display-inline="yes-display-inline">Many people with cancer experience side
			 effects, symptoms, and late complications associated with their disease and
			 their treatment, which can have a serious adverse impact on their health,
			 well-being, and quality of life.</text>
			</paragraph><paragraph id="HEE8FFFED82094C42BD1031D47CA9ECE1"><enum>(2)</enum><text display-inline="yes-display-inline">Many side effects and symptoms associated
			 with cancer and its treatment can be reduced or controlled by the provision of
			 timely symptom management and services and also by educating people with cancer
			 and their caregivers about the potential effects before treatment
			 begins.</text>
			</paragraph><paragraph id="H6A6B0567433840F9A4186CE08A79D9D5"><enum>(3)</enum><text display-inline="yes-display-inline">Studies have found that individualized
			 educational intervention for cancer pain management from a registered nurse was
			 effective for patients with cancer being treated in outpatient and home-based
			 settings. Similarly, the number of caregivers who said they were well informed
			 and confident about caregiving after attending a family caregiver cancer
			 education program increased after program attendance.</text>
			</paragraph><paragraph id="H45300BD11E8B422696C0D11C9EF17854"><enum>(4)</enum><text display-inline="yes-display-inline">People with cancer benefit from having an
			 educational session with oncology nurses in advance of the initiation of
			 treatment to learn how to reduce the risk of and manage adverse effects and
			 maximize well-being. Helping patients to manage their side effects reduces
			 adverse events and the need for urgent or inpatient care.</text>
			</paragraph><paragraph id="HE820F251F2304C0C9F2458CCDBDFF4C1"><enum>(5)</enum><text display-inline="yes-display-inline">The Oncology Nursing Society has received
			 reports from its members that, because the Medicare program and other payers do
			 not cover the provision of patient treatment education, patients and their
			 caregivers often do not receive adequate education before the onset of such
			 patients’ treatment for cancer regarding the course of such treatment and the
			 possible side effects and symptoms such patients may experience. The Oncology
			 Nursing Society recommends that all patients being treated for cancer have a
			 one-on-one educational session with a nurse in advance of the onset of such
			 treatment so that such patients and their caregivers receive the information
			 they need to help minimize adverse events related to such treatment and
			 maximize the well-being of such patients.</text>
			</paragraph><paragraph id="H9596FDDE74B64B07BCDDD8C62F7D5E89"><enum>(6)</enum><text display-inline="yes-display-inline">Insufficient or non-existent Medicare
			 payments coupled with poor investment in symptom management research contribute
			 to the inadequate education of patients, poor management and monitoring of
			 cancer symptoms, and inadequate handling of late effects of cancer and its
			 treatment.</text>
			</paragraph><paragraph id="H674E263D0AA34A4D95BC858B0CCE974F"><enum>(7)</enum><text display-inline="yes-display-inline">People with cancer often do not have the
			 symptoms associated with their disease and the associated treatment managed in
			 a comprehensive or appropriate manner.</text>
			</paragraph><paragraph id="H5DFB6D4C339745D9B23BBE28580B8146"><enum>(8)</enum><text display-inline="yes-display-inline">People with cancer deserve to have access
			 to comprehensive care that includes appropriate treatment and symptom
			 management.</text>
			</paragraph><paragraph id="H56CE7D5C380D4045B3B654A5AE416AD9"><enum>(9)</enum><text display-inline="yes-display-inline">Patients who receive infused chemotherapy
			 likely obtain some treatment education during the course of the administration
			 of their treatment; yet, many do not, and individuals who may receive a
			 different type of cancer care, such as radiation or surgical interventions or
			 oral chemotherapy taken at home, likely do not receive treatment education
			 during their treatment.</text>
			</paragraph><paragraph id="H7F586B40AF7A4D7B9FF7ADAAFD317EE3"><enum>(10)</enum><text display-inline="yes-display-inline">Comprehensive cancer care must include
			 access to services and management associated with nausea, vomiting, fatigue,
			 depression, pain, and other symptoms.</text>
			</paragraph><paragraph id="HA135A0BF5B9C4187AA24F91A0AABAD39"><enum>(11)</enum><text display-inline="yes-display-inline">The Institute of Medicine report, “Ensuring
			 Quality Cancer Care” asserts that <quote>much can be done to relieve the
			 symptoms, ease distress, provide comfort, and in other ways improve the quality
			 of life of someone with cancer. For a person with cancer, maintenance of
			 quality of life requires, at a minimum, relief from pain and other distressing
			 symptoms, relief from anxiety and depressions, including the fear of pain, and
			 a sense of security that assistance with be readily available if
			 needed.</quote>.</text>
			</paragraph><paragraph id="HFFC7F924A5014A38955B9E14F0C424A6"><enum>(12)</enum><text>The Institute of
			 Medicine report, <quote>Cancer Care for the Whole Patient: Meeting Psychosocial
			 Health Needs</quote> recognizes that cancer patients’ psychosocial needs
			 include information about their therapies and the potential side
			 effects.</text>
			</paragraph><paragraph id="H36BC59D245B84A009E5F0615771D85FA"><enum>(13)</enum><text display-inline="yes-display-inline">As more than half of all cancer diagnoses
			 occur among individuals age 65 and older, the challenges of managing cancer
			 symptoms are growing for patients enrolled in the Medicare program.</text>
			</paragraph><paragraph id="HAF50042F56B24C8D8F995F2194984E6B"><enum>(14)</enum><text display-inline="yes-display-inline">Provision of Medicare payment for
			 comprehensive cancer patient treatment education, coupled with expanded cancer
			 symptom management research, will help improve care and quality of life for
			 people with cancer from the time of diagnosis through survivorship or end of
			 life.</text>
			</paragraph></section><title id="H1F8E940CB849465990D684BA8759D63C"><enum>I</enum><header>Comprehensive
			 Cancer Patient Treatment Education Under the Medicare Program</header>
			<section id="H1F5D8016FDB2454D873B25A0B91FEB03"><enum>101.</enum><header>Medicare
			 coverage of comprehensive cancer patient treatment education services</header>
				<subsection id="H0015376A4D0D464F90FEA9105314A93B"><enum>(a)</enum><header>In
			 general</header><text display-inline="yes-display-inline">Section 1861 of the
			 Social Security Act (42 U.S.C. 1395x) is amended—</text>
					<paragraph id="H02C35C2FC8CD4F86A3E3E11C50761891"><enum>(1)</enum><text>in subsection
			 (s)(2)—</text>
						<subparagraph id="HB8A7097B7D68437CA8331C86F070A675"><enum>(A)</enum><text>by striking
			 <quote>and</quote> at the end of subparagraph (EE);</text>
						</subparagraph><subparagraph id="H97B7BBF458974CE88EFDA5162649677E"><enum>(B)</enum><text>by adding
			 <quote>and</quote> at the end of subparagraph (FF); and</text>
						</subparagraph><subparagraph id="H964A34DA03E348E484B5B12F89C181D7"><enum>(C)</enum><text>by adding at the
			 end the following new subparagraph:</text>
							<quoted-block display-inline="no-display-inline" id="HE10FBD6FC26A47B69F7216897B44A3E5" style="traditional">
								<subparagraph id="H7418902CABD94809BA04B95DA1CAC3E9" indent="up1"><enum>(GG)</enum><text>comprehensive cancer patient
				treatment education services (as defined in subsection
				(iii)(1));</text>
								</subparagraph><after-quoted-block>;
				and</after-quoted-block></quoted-block>
						</subparagraph></paragraph><paragraph id="H475DE62D14654261B749C104FE05D448"><enum>(2)</enum><text>by adding at the
			 end the following new subsection:</text>
						<quoted-block display-inline="no-display-inline" id="H4C7C7FE7F2B044FBB453EC6A776888F8" other-style="archaic" style="other">
							<subsection id="H1B9E34093EC6448495DEE922ACFE46CD"><enum>(iii)</enum><header>Comprehensive cancer patient treatment education
		  services</header><paragraph commented="no" display-inline="yes-display-inline" id="H880382AD20C745E68E9D35F4E92CD0E7"><enum>(1)</enum><text display-inline="yes-display-inline">The term <term>comprehensive cancer patient
				treatment education services</term> means—</text>
									<subparagraph id="HE44F0E50F49442F4AA08922C33E46C74" indent="up1"><enum>(A)</enum><text display-inline="yes-display-inline">in
				the case of an individual who is diagnosed with cancer, the provision of a
				one-hour patient treatment education session delivered by a registered nurse
				that—</text>
										<clause id="H8BF2DFBD3D36461C8038FD67A9ED3B48"><enum>(i)</enum><text display-inline="yes-display-inline">is furnished to the individual and the
				caregiver (or caregivers) of the individual in advance of the onset of
				treatment and to the extent practicable, is not furnished on the day of
				diagnosis or on the first day of treatment;</text>
										</clause><clause id="H2FC3AA1FFC564314ACB3321C902D7C5A"><enum>(ii)</enum><text display-inline="yes-display-inline">educates the individual and such caregiver
				(or caregivers) to the greatest extent practicable, about all aspects of the
				care to be furnished to the individual, informs the individual regarding any
				potential symptoms, side-effects, or adverse events, and explains ways in which
				side effects and adverse events can be minimized and health and well-being
				maximized, and provides guidance regarding those side effects to be reported
				and to which health care provider the side effects should be reported;</text>
										</clause><clause id="H1B878D23E18C4149A826821C08264C28"><enum>(iii)</enum><text display-inline="yes-display-inline">includes the provision, in written form, of
				information about the course of treatment, any responsibilities of the
				individual with respect to self-dosing, and ways in which to address symptoms
				and side-effects; and</text>
										</clause><clause id="H2FAA7A8EDC624004BAB0C36D3EBDD568"><enum>(iv)</enum><text display-inline="yes-display-inline">is furnished, to the greatest extent
				practicable, in an oral, written, or electronic form that appropriately takes
				into account cultural and linguistic needs of the individual in order to make
				the information comprehensible to the individual and such caregiver (or
				caregivers); and</text>
										</clause></subparagraph><subparagraph id="HA448F0930D714851A9201B2C87F70177" indent="up1"><enum>(B)</enum><text display-inline="yes-display-inline">with respect to an individual for whom a
				course of cancer treatment or therapy is materially modified, a one-hour
				patient treatment education session described in subparagraph (A), including
				updated information on the matters described in such subparagraph should the
				individual’s oncologic health care professional deem it appropriate and
				necessary.</text>
									</subparagraph></paragraph><paragraph id="H1F1A3C3291B94C36A23AD858B9F0FF73" indent="up1"><enum>(2)</enum><text display-inline="yes-display-inline">In establishing standards to carry out
				paragraph (1), the Secretary shall consult with appropriate organizations
				representing providers of oncology patient treatment education services and
				organizations representing people with
				cancer.</text>
								</paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block>
					</paragraph></subsection><subsection id="HD75001DEF9A442EC832853A30B6C5BED"><enum>(b)</enum><header>Payment</header><text display-inline="yes-display-inline">Section 1833(a)(1) of such Act (42 U.S.C.
			 1395l(a)(1)) is amended—</text>
					<paragraph id="HD50DEC5F480E46E4BCB908342962DDB5"><enum>(1)</enum><text>by striking
			 <quote>and</quote> before <quote>(Z)</quote>; and</text>
					</paragraph><paragraph id="H75246AF371F84F15A1D878CE951372C1"><enum>(2)</enum><text>by inserting
			 before the semicolon at the end the following: <quote>, and (AA) with respect
			 to comprehensive cancer patient treatment education service (as defined in
			 section 1861(iii)(1)), 150 percent of the payment rate established under
			 section 1848 for diabetes outpatient self-management training services (as
			 defined in section 1861(qq)), determined and applied without regard to any
			 coinsurance</quote>.</text>
					</paragraph></subsection><subsection id="H72274360ED6747A3A325AE0C36FF1EA5"><enum>(c)</enum><header>Coverage</header><text>Section
			 1862(a)(1) of such Act (42 U.S.C. 1395y(a)(1)) is amended—</text>
					<paragraph id="HF21ABE922DAC47DDB3CA3A0CEF1C9913"><enum>(1)</enum><text>in subparagraph
			 (O), by striking <quote>and</quote> at the end;</text>
					</paragraph><paragraph id="H764FF65755E24273BAE0C8CC53DB540C"><enum>(2)</enum><text>in subparagraph
			 (P), by striking the semicolon at the end and inserting <quote>, and</quote>;
			 and</text>
					</paragraph><paragraph id="HAF716C1B9884462C8933D4CD9B38EB69"><enum>(3)</enum><text>by adding at the
			 end the following new subparagraph:</text>
						<quoted-block display-inline="no-display-inline" id="H2A8EB0EF25D145AE9C7D5DC6A87FEBC2" style="traditional">
							<subparagraph id="H172B2C59735A49A192713DABDAAE5831" indent="up1"><enum>(Q)</enum><text display-inline="yes-display-inline">in
				the case of comprehensive cancer patient treatment education services (as
				defined in subsection (iii)(1)) which are performed more frequently than is
				covered under such
				section;</text>
							</subparagraph><after-quoted-block>.</after-quoted-block></quoted-block>
					</paragraph></subsection><subsection id="H649BC65A6315403A9C8E715F650533EF"><enum>(d)</enum><header>No impact on
			 payment for other services</header><text display-inline="yes-display-inline">Nothing in this section shall be construed
			 to affect or otherwise authorize any reduction or modification, in the Medicare
			 payment amounts otherwise established for chemotherapy infusion or injection
			 codes with respect to the calculation and payment of minutes for chemotherapy
			 teaching or related services.</text>
				</subsection><subsection id="H2564423623614A89A1CC8866C9CACF74"><enum>(e)</enum><header>Effective
			 date</header><text display-inline="yes-display-inline">The amendments made by
			 this section shall apply to services furnished on or after the first day of the
			 first calendar year that begins after the date of the enactment of this
			 Act.</text>
				</subsection></section></title><title id="H4B1818EE03BD4778A12A404C3B1C62BC"><enum>II</enum><header>Research on
			 Cancer Symptom Management Improvement</header>
			<section id="HDD88B0627C8746F48208DBDCAE9E717B"><enum>201.</enum><header>Expansion of
			 research</header><text display-inline="no-display-inline">Subpart 1 of part C
			 of title IV of the Public Health Service Act (42 U.S.C. 285 et seq.) is amended
			 by adding at the end the following:</text>
				<quoted-block display-inline="no-display-inline" id="H168220502A5941CE9C7D44B8CC5F1899" style="OLC">
					<section id="HE8C27BA740A44F9DBF440DC7383B0CB9"><enum>417G.</enum><header>Research on
				Cancer Symptom Management Improvement</header>
						<subsection id="H2E5BB5BE862D49FE888CD7472212E2EA"><enum>(a)</enum><header>In
				general</header><text display-inline="yes-display-inline">The Director of NIH
				shall expand, intensify, and coordinate programs for the conduct and support of
				research with respect to—</text>
							<paragraph id="HE7FC0F06716A4F0F922BAC4D01BBBDC9"><enum>(1)</enum><text>improving the
				treatment and management of symptoms and side effects associated with cancer
				and cancer treatment; and</text>
							</paragraph><paragraph id="H139D640B3ED94F89BEC1D647B7D42D76"><enum>(2)</enum><text>evaluating the
				role of nursing interventions in the amelioration of such symptoms and side
				effects.</text>
							</paragraph></subsection><subsection id="HCC70DED155C14F4D8120105F19FD5E24"><enum>(b)</enum><header>Administration</header><text display-inline="yes-display-inline">The Director of NIH shall carry out this
				section—</text>
							<paragraph id="H441499B96B6A462D9C28600B29DA1891"><enum>(1)</enum><text>through the
				Director of the Institute; and</text>
							</paragraph><paragraph id="H366C09B18B864A3ABE046497B7B28F2E"><enum>(2)</enum><text>in collaboration
				with the directors of the National Institute of Nursing Research, the National
				Institute of Mental Health, the National Center on Minority Health and Health
				Disparities, the National Center for Complementary and Alternative Medicine,
				and the Agency for Healthcare Research and
				Quality.</text>
							</paragraph></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block>
			</section><section id="H8D1A995536F54E58BA82A0AE095AA283"><enum>202.</enum><header>Nursing
			 intervention research grants</header><text display-inline="no-display-inline">Subpart 1 of part C of title IV of the
			 Public Health Service Act (42 U.S.C. 285 et seq.), as amended by section 201,
			 is amended by adding at the end the following:</text>
				<quoted-block display-inline="no-display-inline" id="HC01EB7ABF1C4418A95326F3355FE2E54" style="OLC">
					<section id="H3BE36DC60C234FE1AB91FC9131142970"><enum>417H.</enum><header>Nursing
				intervention research grants</header>
						<subsection id="H5CCF531582F24D95A5B38A24CB86E8A8"><enum>(a)</enum><header>In
				general</header><text display-inline="yes-display-inline">The Director of NIH
				shall make grants for research to be conducted—</text>
							<paragraph id="H02480CAC590845B19BB3C96EDA95BA8F"><enum>(1)</enum><text>with a registered
				nurse as the principal investigator; and</text>
							</paragraph><paragraph id="HD91836EEE9374E8FBCCFF32C52B0DD64"><enum>(2)</enum><text>for the purpose of
				studying cancer symptom management care and services delivered by registered
				nurses to cancer patients.</text>
							</paragraph></subsection><subsection id="HA6DD649522994E15AB1D1F2CC5B911FA"><enum>(b)</enum><header>Inclusion of
				national research institutes</header><text display-inline="yes-display-inline">In carrying out this section, the Director
				of NIH shall provide for the participation of the National Cancer Institute,
				the National Institute of Nursing Research, and any other national research
				institute that has been engaged in research described subsection (a)(2).</text>
						</subsection><subsection id="HCBF3895E9134465D8EC0230B7E91D61C"><enum>(c)</enum><header>Authorization of
				appropriations</header><text display-inline="yes-display-inline">There are
				authorized to be appropriated to carry out this section such sums as may be
				necessary for fiscal years 2012 through
				2016.</text>
						</subsection></section><after-quoted-block>.</after-quoted-block></quoted-block>
			</section><section id="H5E7CF76D03224FDE8F010EB08E09CEBB"><enum>203.</enum><header>Institute of
			 Medicine study on the provision of symptom management and supportive care in
			 people with cancer</header>
				<subsection id="H96F5858BDEFE414993B0B22019D7A242"><enum>(a)</enum><header>Report</header>
					<paragraph id="H605B255A4DE348BDB24974258FF0FEEA"><enum>(1)</enum><header>In
			 general</header><text display-inline="yes-display-inline">Not later than 2
			 months after the date of enactment of this Act, the Secretary of Health and
			 Human Services (in this section referred to as the “Secretary”) shall enter
			 into an arrangement under which the Institute of Medicine of the National
			 Academy of Sciences (in this section referred to as the “Institute”) shall
			 conduct a study and evaluation, including a report, on the current state of
			 symptom management, patient treatment education, and supportive care given to
			 people with cancer.</text>
					</paragraph><paragraph id="H4ACDEA38179547FC8071B244225A7E36"><enum>(2)</enum><header>Specific matters
			 evaluated</header><text display-inline="yes-display-inline">In conducting the
			 study and evaluation under paragraph (1), the Institute shall—</text>
						<subparagraph id="HEA83909CA9AA40708157AFA03CC8DFF1"><enum>(A)</enum><text display-inline="yes-display-inline">analyze any barriers to access to, and
			 delivery of, symptom management, patient treatment education, and supportive
			 care to people with cancer;</text>
						</subparagraph><subparagraph id="H29591AA4C5DB4C4DAC5D83EDA679D069"><enum>(B)</enum><text display-inline="yes-display-inline">catalogue and evaluate the incentives and
			 disincentives in the current reimbursement system that influence whether
			 individuals receive comprehensive symptom management, patient treatment
			 education, and supportive care, including adequate and ongoing patient
			 treatment education;</text>
						</subparagraph><subparagraph id="H7654C450D596444E9E02DB7AC88D2CDE"><enum>(C)</enum><text display-inline="yes-display-inline">evaluate the importance of nursing
			 interventions in the management of symptoms and side effects of cancer and the
			 associated treatment;</text>
						</subparagraph><subparagraph id="HF825C4568F4248DA8E6C602C0EBF2D37"><enum>(D)</enum><text display-inline="yes-display-inline">consider such other matters as the
			 Institute determines appropriate; and</text>
						</subparagraph><subparagraph id="HB0919534B881451AA7347B7CF69DDC1F"><enum>(E)</enum><text display-inline="yes-display-inline">make recommendations to address any
			 barriers, challenges, or other issues identified through the study and
			 evaluation.</text>
						</subparagraph></paragraph><paragraph id="HEED787D0A1864AD0B3018F458C0919F6"><enum>(3)</enum><header>Scope of
			 review</header><text display-inline="yes-display-inline">In conducting such
			 study and evaluation, the Institute shall consider a variety of perspectives,
			 including the perspectives of patients and their family caregivers, registered
			 nurses, including nurses certified in oncology, physicians, social workers,
			 psychologists, other health care professionals, and other experts and
			 stakeholders.</text>
					</paragraph></subsection><subsection id="HC3236BE07F90449C96BA99FF9316B094"><enum>(b)</enum><header>Report</header><text display-inline="yes-display-inline">Not later than 18 months after the date of
			 enactment of this Act, the arrangement under subsection (a) shall provide for
			 the Institute to submit to the Secretary and to Congress a report on the study
			 evaluation conducted under such subsection. Such report shall contain a
			 detailed description of the findings of such study and evaluation and
			 recommendations for improving the provision of symptom management, patient
			 treatment education, and supportive care to people with cancer.</text>
				</subsection><subsection id="H05FAF1A6AE8A4F739834F43410C91E56"><enum>(c)</enum><header>Authorization of
			 appropriations</header><text display-inline="yes-display-inline">There are
			 authorized to be appropriated such sums as may be necessary for the purposes of
			 conducting the study and evaluation, and preparing the report, required by this
			 section.</text>
				</subsection></section></title></legis-body>
</bill>
